26th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190192418 | Processes and Compositions Obtained from the Solanum Genus of Plants | 2019-06-27 |
20190192419 | PORE MINIMIZER | 2019-06-27 |
20190192420 | USE OF A REVERSE-MICELLAR SYSTEM FOR DELIVERING CHELATORS OF RADIONUCLIDES AND METALS | 2019-06-27 |
20190192421 | ORAL TRANSMUCOSAL COMPOSITIONS INCLUDING AROMATASE INHIBITORS FOR LOW TESTOSTERONE LEVELS IN MEN | 2019-06-27 |
20190192422 | A DOSAGE FORM FOR VAPORIZATION AND SMOKING | 2019-06-27 |
20190192423 | Slow Release Pharmaceutical Composition Made of Microparticles | 2019-06-27 |
20190192424 | Injectable Slurries and Methods of Manufacturing the Same | 2019-06-27 |
20190192425 | CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS | 2019-06-27 |
20190192426 | TREATMENT PROCESS OF CYCLOSPORINE EYE GEL | 2019-06-27 |
20190192427 | AZOLE COMPOUND OPHTHALMIC PREPARATION | 2019-06-27 |
20190192428 | ORAL CANNABINOID FORMULATIONS | 2019-06-27 |
20190192429 | SUBLINGUAL FORMULATIONS COMPRISING CANNABIS RESIN, METHODS FOR MAKING SAME AND USES THEREOF | 2019-06-27 |
20190192430 | GELLING COMPOSITIONS FOR TREATING MALIGNANT TUMOURS AND/OR PREVENTING TUMOUR RECURRENCE | 2019-06-27 |
20190192431 | DISPERSION PROCESS OF ADAPALENE IN A GEL PREPARATION | 2019-06-27 |
20190192432 | MULTI-FUNCTIONAL PARTICLES AND METHODS OF USING THE SAME | 2019-06-27 |
20190192433 | NO-RINSE CHEMICAL FOAM COMPRISING IVERMECTIN | 2019-06-27 |
20190192434 | LIPOSOME FORMULATION AND MANUFACTURE | 2019-06-27 |
20190192435 | LIPID-DERIVED NEUTRAL NANOPARTICLES | 2019-06-27 |
20190192436 | PRODRUG COMPOSITIONS, PRODRUG NANOPARTICLES, AND METHODS OF USE THEREOF | 2019-06-27 |
20190192437 | POWDER FORM AND USE OF HYDROGEL COMPOSITIONS FOR ALLEVIATING DEGENERATIVE JOINT AND TENDON TEAR | 2019-06-27 |
20190192438 | METHOD FOR PREPARING DEGRADABLE DRUG-LOADED MICROSPHERE FOR EMBOLIZATION, AND PRODUCT OBTAINED THEREFROM | 2019-06-27 |
20190192439 | MICROPARTICLES FOR ENCAPSULATING PROBIOTICS, OBTAINING SAID MICROPARTICLES AND USES THEREOF | 2019-06-27 |
20190192440 | ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES | 2019-06-27 |
20190192441 | ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS | 2019-06-27 |
20190192442 | ROOM TEMPERATURE STABLE ORAL CALCITONIN FORMULATION | 2019-06-27 |
20190192443 | SOLUBILIZED COQ-10 | 2019-06-27 |
20190192444 | COMPOSITIONS AND METHODS FOR SELECTIVE GI TRACT DELIVERY | 2019-06-27 |
20190192445 | TOPICAL PHARMACEUTICAL COMPOSITIONS | 2019-06-27 |
20190192446 | TOPICAL PHARMACEUTICAL COMPOSITIONS | 2019-06-27 |
20190192447 | COMPOSITIONS CONTAINING THYMOHYDROQUINONE AND THEIR METHOD OF PREPARATION | 2019-06-27 |
20190192448 | COMPOSITIONS FOR THE MANAGEMENT OF HYPERGLYCEMIA AND RELATED CONDITIONS | 2019-06-27 |
20190192449 | COMPOSITION AND USE THEREOF | 2019-06-27 |
20190192450 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2019-06-27 |
20190192451 | SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS | 2019-06-27 |
20190192452 | HIF-1 MODULATOR PAINT FORMULATION AND USES THEREOF | 2019-06-27 |
20190192453 | METHODS FOR IMPROVING PHYSICAL PERFORMANCE AND CAPSICUM COMPOSITIONS USED THEREIN | 2019-06-27 |
20190192454 | METHODS FOR TREATING CANCER WITH RORGAMMA INHIBITORS | 2019-06-27 |
20190192455 | USE OF CELIPROLOL FOR TREATING KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME | 2019-06-27 |
20190192456 | USE OF CELIPROLOL FOR TREATING VASCULAR EHLERS-DANLOS SYNDROME IN WOMEN DURING PREGNANCY AND PERIPARTUM PERIOD | 2019-06-27 |
20190192457 | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT | 2019-06-27 |
20190192458 | THERAPEUTIC/PROPHYLACTIC AGENT FOR GRAFT-VERSUS-HOST DISEASE, FIBROCYTE INVASION INHIBITOR, AND INHIBITOR AGAINST TEAR REDUCTION AND REDUCTION IN GOBLET CELLS | 2019-06-27 |
20190192459 | Treatment of intrahepatic cholestatic diseases | 2019-06-27 |
20190192460 | ORAL COMBINATION DRUG FORMULATION COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND A COMPLEMENTARY LOW DOSE OF TRANEXAMIC ACID FOR THE TREATMENT OF MENSTRUAL PAIN ACCOMPANIED WITH EXCESSIVE MENSTRUAL BLOOD LOSS | 2019-06-27 |
20190192461 | SMALL MOLECULE INHIBITORS OF STAT3 WITH ANTI-TUMOR ACTIVITY | 2019-06-27 |
20190192462 | COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE | 2019-06-27 |
20190192463 | Methods and compositions for the treatment of diabetes and related systems | 2019-06-27 |
20190192464 | BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS | 2019-06-27 |
20190192465 | METHODS OF TREATING CHRONIC DRY EYE DISEASE USING C16:1n7-PALMITOLEATE AND DERIVATIVES THEREOF | 2019-06-27 |
20190192466 | METHOD OF USING OMEGA 3 FATTY ACIDS TO TREAT DISEASES WHICH INVOLVE DAMAGE TO THE NERVOUS SYSTEM | 2019-06-27 |
20190192467 | COMPOSITIONS INCLUDING ENCAPSULATED ISOTRETINOIN AND METHODS FOR USE THEREOF | 2019-06-27 |
20190192468 | METHODS FOR TREATMENT OF ADENOID CYSTIC CARCINOMA | 2019-06-27 |
20190192469 | OLEOCANTHAL ISOLATION AND CANCER TREATMENT | 2019-06-27 |
20190192470 | Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms | 2019-06-27 |
20190192471 | HALOGENATED ESTERS OF CYCLOPROPANATED UNSATURATED FATTY ACIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-06-27 |
20190192472 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT AT RISK FOR CARDIOVASCULAR DISEASE | 2019-06-27 |
20190192473 | Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea | 2019-06-27 |
20190192474 | Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer | 2019-06-27 |
20190192475 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | 2019-06-27 |
20190192476 | ESTROGEN RECEPTOR LIGANDS, COMPOSITIONS AND METHODS RELATED THERETO | 2019-06-27 |
20190192477 | NANOPARTICLE COMPOSITIONS OF ALBUMIN AND PACLITAXEL | 2019-06-27 |
20190192478 | NLRP3 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY SKIN DISORDERS | 2019-06-27 |
20190192479 | IMMUNOMODULATOR | 2019-06-27 |
20190192480 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LIVER DISEASES, CONTAINING, AS ACTIVE INGREDIENT, CROMOLYN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2019-06-27 |
20190192481 | METHOD FOR TREATING ZIKA VIRUS INFECTION WITH QUERCETIN-CONTAINING COMPOSITIONS | 2019-06-27 |
20190192482 | AGENT FOR ELIMINATING SENESCENT CELLS | 2019-06-27 |
20190192483 | LOCAL DELIVERY OF CHOLESTEROL-LOWERING DRUGS TO TREAT AND PREVENT BACTERIAL VAGINOSIS | 2019-06-27 |
20190192484 | TREATMENT OF TNF- alpha CYTOTOXICITY | 2019-06-27 |
20190192485 | DOSAGE REGIMEN FOR THE TREATMENT OF ENDOMETRIOSIS | 2019-06-27 |
20190192486 | Use of Isoxazoline Derivatives for the Treatment or Prevention of Arthropod Infestations in Poultry | 2019-06-27 |
20190192487 | INHIBITORS OF BACTERIAL TWO COMPONENT SIGNAL TRANSDUCTION SYSTEM AND USES THEREOF | 2019-06-27 |
20190192488 | USE OF MITOCHONDRIAL ACTIVITY INHIBITORS FOR THE TREATMENT OF POOR PROGNOSIS ACUTE MYELOID LEUKEMIA | 2019-06-27 |
20190192489 | HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY | 2019-06-27 |
20190192490 | RIFAXIMIN READY-TO-USE SUSPENSION | 2019-06-27 |
20190192491 | DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS | 2019-06-27 |
20190192492 | PIERICIDIN BACTERIAL INHIBITORS | 2019-06-27 |
20190192494 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE | 2019-06-27 |
20190192495 | USES OF A LYSYL OXIDASE-LIKE 2 INHIBITOR | 2019-06-27 |
20190192496 | USE OF PRIDOPIDINE FOR TREATING DYSTONIAS | 2019-06-27 |
20190192497 | ANTIBODY-RECRUITING MOLECULES FOR THE TREATMENT OF CANCER | 2019-06-27 |
20190192498 | PSILOCYBIN COMPOSITIONS | 2019-06-27 |
20190192499 | ATROPINE PHARMACEUTICAL COMPOSITIONS | 2019-06-27 |
20190192500 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | 2019-06-27 |
20190192501 | METHODS FOR TREATING PTEN-MUTANT TUMORS | 2019-06-27 |
20190192502 | Modulation of Transcription Initiation Factor TFIID Subunit 1 (TAF1) for Treating Leukemia | 2019-06-27 |
20190192503 | NOVEL METHODS OF TREATING A NEURODEGENERATIVE DISEASE IN A MAMMAL IN NEED THEREOF | 2019-06-27 |
20190192504 | Therapeutic heterocyclic compounds | 2019-06-27 |
20190192506 | TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE | 2019-06-27 |
20190192507 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2019-06-27 |
20190192508 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY | 2019-06-27 |
20190192509 | Stem Cell Modulation II | 2019-06-27 |
20190192510 | GPR119 AGONIST | 2019-06-27 |
20190192511 | AMORPHOUS SOLID DISPERSIONS | 2019-06-27 |
20190192512 | HETEROARYL COMPOUNDS AND USES THEREOF | 2019-06-27 |
20190192513 | Detection and Treatment of Excessive Hair Shedding | 2019-06-27 |
20190192514 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | 2019-06-27 |
20190192515 | 1-PYRAZOLYL-3-(4-((2-ANILINOPYRIMIDIN-4 -YL) OXY) NAPTHTHALEN-1 - YL) UREAS AS P38 MAP KNASE INHIBITORS | 2019-06-27 |
20190192516 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | 2019-06-27 |
20190192517 | TREATMENT OF SQUAMOUS CELL CARCINOMAS WITH INHIBITORS OF ERK | 2019-06-27 |
20190192518 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS | 2019-06-27 |
20190192519 | NOVEL USES | 2019-06-27 |